HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution.

Abstract
Posterior reversible encephalopathy syndrome (PRES) is defined by a spectrum of clinical symptoms and characteristic radiologic findings. Most patients show clinical recovery and normalization of imaging, even though a subset of rare cases may progress to cytotoxic edema, irreversible damage, and persistent radiological findings. As the condition is transient and seldom leads to death, few reports of pathologic findings during an acute episode or in patients following a resolved episode are available. Here, we describe the neuropathologic findings at autopsy in a 62-year-old woman with a history of systemic lupus erythematosus (SLE) and an episode of PRES that had resolved radiologically and clinically ~ 4.5 years prior to death. Autopsy findings included diffuse rarefaction of white matter with scattered microinfarcts, subpial gliosis, as well as perivascular lymphocytic aggregates and hemosiderin deposition in the sections from the posterior cerebrum. Some but not all of these changes of chronic white matter damage may be attributed to the coexisting systemic lupus erythematosus. Thus, we conclude that pathologic evidence of partial irreversible damage can be documented in PRES in spite of radiographic resolution of abnormalities.
AuthorsCyril Jacquot, Christine M Glastonbury, Tarik Tihan
JournalClinical neuropathology (Clin Neuropathol) 2015 Jan-Feb Vol. 34 Issue 1 Pg. 26-33 ISSN: 0722-5091 [Print] Germany
PMID25074877 (Publication Type: Case Reports, Journal Article)
Topics
  • Autopsy
  • Brain (diagnostic imaging, pathology)
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (complications)
  • Middle Aged
  • Posterior Leukoencephalopathy Syndrome (complications, diagnostic imaging, pathology)
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: